Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| cancer case prostate study |
|
Cryocare PCA - The Cryocare PCA Prostate Cancer Case Studies Cryoablation In High Risk Cases Stephen Scionti, MD > Read Case Study "Our findings indicate that Cryocare TCAP is a viable prostate cancer treatment. Prostate Cancer Research - education, controversies, reviews Prostate cancer research and education including prostate cancer controversies and links to The initial Case Study followed by â˜Comments from Authorâ™. FasterCures: Case Study: Prostate Cancer Discussion of Prostate Cancer in the Fastercures Report: Summit on Innovation in Disease Research. Prostate Cancer This case study will take you through the clinical journey of a patient with prostate cancer. You need to answer each question correctly before you will be A case-control study of diet and prostate cancer. We interviewed 328 men diagnosed with prostate cancer before the age of 75 years and 328 age-matched population controls. The principal hypotheses were that Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a The study included 692 incident prostate cancer cases, diagnosed 1 to 8 years after study entry, including 270 aggressive cases, with regional or distant Confirmation study of prostate cancer risk variants at 8q24 in The objective of this study was to confirm the association of 8q24 markers with prostate cancer in African Americans. We genotyped 24 markers along 8q24 and Genome-wide association study of prostate cancer identifies a Genome-wide association study of prostate cancer identifies a second risk 4296 cases and 4299 controls) confirms association with prostate cancer for Prostate Cancer Case study about Prostate Cancer. Prostate cancer was diagnosed. Based on his PSA, DRE and findings on TRUS and core biopsies it was felt he had a Prostate Cancer Case Studies - ProstateLine.com Access detailed prostate cancer case studies. UK); Case study 1 - 59-year-old general practitioner sought routine PSA testing for â˜reassuranceâ™ after |
| cancer case prostate study |
|
dallas in prostatectomy robotic cartoon exam prostate cancer lupron prostate enlarged prostate picture |